NCT07123909Recruiting
Studies on Adsorption International Learning Initiative Global
The Use of Sorption Technologies in Patients Receiving Program Hemodialysis With Inflammatory Syndrome
Source: ClinicalTrials.gov · Last updated 10 Dec 2025
Brief summary (registry, in English)
Use of sorption technologies in patients undergoing maintenance hemodialysis with inflammatory syndrome and clinical manifestations of uremia
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 4 Jul 2025
- Start date
- 1 Jun 2025
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- Botkin Hospital
- Diseases
- Chronic kidney disease
- NCT number
- NCT07123909
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Jun 2025 to the primary completion date, 31 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of steroids or immunosuppressive therapy
Other illness
- History of kidney transplantation
- Diagnosis of cancer
Other
- Pregnancy
Who the study is looking for
- Adequate dialysis defined by a KT/V index ≥ 1.4
- No active inflammatory process or infection
- Age ≥ 18 years
- Receiving standard hemodialysis regimen three times weekly, at least 4 hours per session
- Participants with elevated interleukin-6 (IL-6) and/or C-reactive protein (CRP) levels exceeding local laboratory reference values
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Botkin Hospital Coordinator of this site? Confirm its status | Moscow | Russia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.